(Q37420069)

20 August 2017

Vitamin E treatment for children with chronic hepatitis B: a randomized placebo controlled trial (English)

1 reference

20 August 2017

0 references

0 references

1 reference

1 reference

Patrick Gerner

1

1 reference

20 August 2017

Hans-Georg Posselt

2

1 reference

20 August 2017

Andreas Krahl

3

1 reference

20 August 2017

Antje Ballauff

4

1 reference

20 August 2017

Albina Innerhofer

5

1 reference

20 August 2017

Christa Binder

6

1 reference

20 August 2017

Tobias G Wenzl

7

1 reference

20 August 2017

Matthias Zense

8

1 reference

20 August 2017

Ariadne Hector

9

1 reference

20 August 2017

Gerhard Dockter

10

1 reference

20 August 2017

Rüdiger Adam

11

1 reference

20 August 2017

Jenny Neubert

12

1 reference

20 August 2017

Martin Classen

13

1 reference

20 August 2017

Robert van Gemmern

14

1 reference

20 August 2017

Stefan Wirth

15

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 December 2008

1 reference

World Journal of Gastroenterology

20 August 2017

1 reference

20 August 2017

14

1 reference

20 August 2017

47

1 reference

20 August 2017

7208-7213

1 reference

Incidence and routes of transmission of hepatitis B virus in England and Wales, 1995-2000: implications for immunisation policy.

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776878

EASL International Consensus Conference on Hepatitis B. 13-14 September, 2002: Geneva, Switzerland. Consensus statement (short version).

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776878

Long term effect of alpha interferon in children with chronic hepatitis B.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776878

Vitamin E supplementation and in vivo immune response in healthy elderly subjects. A randomized controlled trial

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776878

The epidemiology and prophylaxis of hepatitis B in sub-Saharan Africa: a view from tropical and subtropical Africa

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776878

Importance of perinatal versus horizontal transmission of hepatitis B virus infection in China

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776878

Tolerance and safety of vitamin E: A toxicological position report

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776878

A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776878

Different cytokine profiles of intraphepatic T cells in chronic hepatitis B and hepatitis C virus infections.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776878

Factors affecting clearance of hepatitis B e antigen in hepatitis B surface antigen carrier children.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776878

Long-term outcome of chronic type B hepatitis in patients who acquire hepatitis B virus infection in childhood

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776878

Vitamin E supplementation enhances cell-mediated immunity in healthy elderly subjects

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776878

Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776878

A Pilot Study of Thymosin .ALPHA.1 Therapy for Chronic Hepatitis B Patients

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776878

Clinical trial of lamivudine in children with chronic hepatitis B.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776878

Thymosin alpha in the treatment of chronic hepatitis B: an uncontrolled open-label trial.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776878

Vitamin E as treatment for chronic hepatitis B: results of a randomized controlled pilot trial.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776878

Thymosin alpha1 treatment of chronic hepatitis B: results of a phase III multicentre, randomized, double-blind and placebo-controlled study

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776878

Combination alpha-interferon and lamivudine therapy for alpha-interferon-resistant chronic hepatitis B infection: results of a pilot study

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776878

Safety and efficacy of interferon retreatment in children with chronic hepatitis B.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776878

Interferon alfa therapy for chronic hepatitis B in children: a multinational randomized controlled trial.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776878

Lymphoblastoid interferon alfa with or without steroid pretreatment in children with chronic hepatitis B: a multicenter controlled trial

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776878

Sustained disease remission after spontaneous HBeAg seroconversion is associated with reduction in fibrosis progression in chronic hepatitis B Chinese patients

2 September 2018

1 reference

12 December 2020

Chronic hepatitis B: update of recommendations

1 reference

12 December 2020

Levamisole therapy in chronic type B hepatitis. Results of a double-blind randomized trial

1 reference

12 December 2020

PLACEBO-CONTROLLED TRIAL OF RECOMBINANT α2-INTERFERON IN CHINESE HBsAg-CARRIER CHILDREN

1 reference

12 December 2020

Long-term remission of chronic hepatitis B after alpha-interferon therapy

1 reference

12 December 2020

Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B

1 reference

12 December 2020

Nutritional status and immune responses in mice with murine AIDS are normalized by vitamin E supplementation

1 reference

12 December 2020

A randomized controlled trial of thymopentin therapy in patients with chronic hepatitis B

1 reference

12 December 2020

Evaluation of efficacy and safety of thymus humoral factor-gamma 2 in the management of chronic hepatitis B

1 reference

12 December 2020

Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B

1 reference

12 December 2020

Diminished plasma levels of vitamin E in patients with severe viral hepatitis

1 reference

12 December 2020

Vitamin E improves the aminotransferase status of patients suffering from viral hepatitis C: a randomized, double-blind, placebo-controlled study

1 reference

12 December 2020

Lamivudine as initial treatment for chronic hepatitis B in the United States

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.14.7208

1 reference

20 August 2017

1 reference

20 August 2017

PubMed publication ID

19084935

1 reference